Premium

Pfizer CEO Claims Cancer Is 'New COVID,’ Promises New Vaxes

Gian Ehrenzeller/Keystone via AP, File

Pfizer hype-man Dr. Albert Bourla (a veterinarian, not a human doctor) is now promising shareholders a massive return on investment for next-gen cancer “vaccines” using the same mRNA technology as the COVID shots:

Oncology, it is our new COVID. We did what we did with Covid. We are very proud to have saved the world but it is behind us now. We want to do [it] once more and I think oncology is our best chance to do it…
 They will be blockbuster drugs.

“That is such music to so many of our viewers’ ears,” coos the Fox News actress. “Props to the wonderful people at Pfizer.”

Cancer research has for many years been a goldmine for the pharmaceutical industry, as early-onset cancer rates spiked by 79% from 1990 to 2019 — basically an 80% increase in less than twenty years.

One not need be a statistician to understand this is an astronomical spike that, in a country with a government that actually cared about its citizens, would demand immediate investigation and probably criminal penalties.

Instead, we get more drugs.  

Chances are you know at least one kid with cancer in your own life — which used to be such an anomaly that child oncologists would travel across the country just to glimpse and study one.

Via British Medical Journal (emphasis added):

Global incidence of early-onset cancer increased by 79.1% and the number of early-onset cancer deaths increased by 27.7% between 1990 and 2019. Early-onset breast, tracheal, bronchus and lung, stomach and colorectal cancers showed the highest mortality and DALYs in 2019. Globally, the incidence rates of early-onset nasopharyngeal and prostate cancer showed the fastest increasing trend, whereas early-onset liver cancer showed the sharpest decrease. Early-onset colorectal cancers had high DALYs within the top five ranking for both men and women. High-middle and middle Sociodemographic Index (SDI) regions had the highest burden of early-onset cancer.

And that was before the COVID-19 vax scam.

Things have changed since 2019. When the numbers finally come in, I would bet dollars to donuts the 2019-2039 spike will be in triple or quadruple digits.

Via Epoch Times (emphasis added):

Microbiologist Kevin McKernan and his team recently discovered simian virus 40 (SV40) promoters in Pfizer’s and Moderna’s bivalent mRNA COVID shots...

...Jessica Rose, who holds a doctorate in computational biology, interviews microbiologist Kevin McKernan on “Good Morning CHD.” McKernan’s team recently discovered simian virus 40 (SV40) promoters in Pfizer’s and Moderna’s bivalent mRNA COVID shots. For decades, SV40 has been suspected of causing cancer in humans…

Several methods were deployed to assess the nucleic acid composition of four expired vials of the Moderna and Pfizer bivalent mRNA vaccines. Two vials from each vendor were evaluated … Multiple assays support DNA contamination that exceeds the European Medicines Agency (EMA) 330 ng/mg requirement and the FDA’s 10 ng/dose requirements…

Equally—if not more—troubling, these DNA contaminants can also alter the human genome. As Mr. McKernan explains, genomic sequencing involves reading the letters of the genome, A, T, C, and G, which make up the DNA code. Both DNA and RNA can be sequenced in this manner.

Pathological, self-perpetuating alterations to the human genome that spread throughout the body are otherwise called “cancer.”

Via Cureus (emphasis added):

Statistically significant increases in age-adjusted mortality rates of all cancer and some specific types of cancer, namely, ovarian cancer, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers, were observed in 2022 after two-thirds of the Japanese population had received the third or later dose of SARSCoV-2 mRNA-LNP vaccine. These particularly marked increases in mortality rates of these ERα-sensitive cancers may be attributable to several mechanisms of the mRNA-LNP vaccination rather than COVID-19 infection itself or reduced cancer care due to the lockdown. The significance of this possibility warrants further studies.

Joe Biden, interestingly, since he served as vice president, has been at the helm of something called “Cancer Moonshot.”

Via The White House:

The Cancer Moonshot is a White House initiative to bring renewed leadership to the fight against cancer, facilitate new collaborations, and drive progress across the cancer journey utilizing all facets of the oncology community – federal agencies and departments, private companies, healthcare providers, patient groups, philanthropies, and all Americans.

Lo and behold!

The “Cancer Moonshot” gravy train, invented during the Obama administration and handed to Biden, includes top Pfizer executives, with hundreds of millions, possibly billions, of dollars in government cash funneled to private research firms on the line, in addition to access to data and research conducted by the government on the public dime.

Via Modern Healthcare (emphasis added):

Greg Simon, a cancer survivor and former pharmaceutical executive, has been appointed by Vice President Joe Biden as the executive director of the Cancer Moonshot Task Force, according to news reports.

Simon, 64, has experience in the private and public sectors. He previously served as senior vice president for patient engagement at Pfizer. Most recently, he was CEO of New York-based Poliwogg, a company that invests in the life sciences sector of healthcare. In 2003, he founded the not-for-profit FasterCures, a center of the Milken Institute that aims to speed up and improve medical research.

In 2014, Simon was diagnosed with chronic lymphocytic leukemia. He finished his first round of chemotherapy six months ago, according to the New York Times.

Via Stat News, April 2016 (emphasis added):

More than two dozen leading cancer researchers and advocates will advise Vice President Joe Biden’s cancer moonshot initiative as members of the Blue Ribbon Panel announced by the Obama administration Monday.

They come from top research institutes and cancer centers like the University of Texas MD Anderson Cancer Center and Harvard Medical School, as well as pharmaceutical companies like Pfizer, and advocacy groups like Friends of Cancer Research.

Over the next few months, the panel will develop recommendations for the National Institutes of Health on everything from cancer vaccines to early detection to data sharing. It will also explore what research could be supported by a special funding stream proposed by President Obama in his most recent budget, part of a $755 million plan to fund the cancer initiative.

"Fascism should more appropriately be called Corporatism because it is a merger of state and corporate power." —Benito Mussolini

All that to say: isn’t it remarkable how little attention is paid to the root causes of cancer — Kamala Harris being notoriously obsessed with illegal immigration’s “root causes" — but rather the entire focus is on profiteering off of said cancer?

Recommended

Trending on PJ Media Videos

Advertisement
Advertisement